Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UBC researcher discovers ’control room’ that regulates immune responses

22.10.2003


The approximately 50 million people in the U.S. who suffer from autoimmune diseases like HIV/AIDS, multiple sclerosis, and arthritis, may soon be able to control their immune responses, thanks to a breakthrough discovery by a researcher at the University of British Columbia in Vancouver, Canada.



Wilfred Jefferies, a professor at UBC’s Biotechnology Laboratory, has discovered and characterized the mechanics of a cellular pathway that triggers immune responses. He and his team have also uncovered a specialized cell substructure, or organelle, that dictates exactly how the immune system will be activated.

"This discovery opens the door to the immune system control room," says Jefferies, who is also a member of UBC’s Biomedical Research Centre. "We’ve found a mechanism that appears to act like a dial – it can turn immune system response up or down."


Jefferies believes that it will take about five years for scientists to use this information to create new therapies – such as medication or vaccines – to regulate immune responses in humans.

The findings have enormous implications for patients because treatment may be targeted by adjusting the "dial", says Jefferies. Immune responses may be increased to fight infection or reduced to help the body accept transplanted tissue or organs.

The work was recently published online in Nature Immunology and will be the topic of an editorial when the journal appears on newsstands in November.

The research findings can be used immediately to test exactly how the immune system responds to a variety of pathogenic organisms, including bacteria, viruses and tumours, says Jefferies, who is a member of UBC’s departments of Microbiology and Immunology, Medical Genetics and Zoology.

Jefferies’ research focuses on dendritic cells. A network of specialized cells, dendritic cells act as sentinels of the immune system, detecting and relaying information about illness-causing organisms or pathogens. Jefferies and his team have identified a new organelle within dendritic cells that sorts pathogens without being harmed by them and controls signals given to the immune system. The signals turn immune responses up or down, according to the type of pathogen encountered.

The immune system protects the body from potentially harmful substances such as microorganisms, toxins, cancer cells, and blood or tissues from another person. Immune system disorders are conditions where the immune response is over-active, reduced or absent.


The research team includes UBC graduate students Greg Lizee, Jacqueline Tiong, Meimei Tian and Kaan Biron as well as post-doctoral fellow Gene Basha. UBC researchers, who conduct more than 5,225 investigations annually, attracted $377 million in research funding in 2002 / 2003.

NB. Editors: Electronic images of Dr. Jefferies as well as dendrite cells are available. A brief biography is attached.

Wilfred Jefferies

Prof. Wilfred Jefferies completed his PhD at Oxford University after obtaining a BSc from University of Victoria in British Columbia.

His completed research training at centres that include Sweden’s Ludwig Institute for Cancer Research, part of the Karolinska Institute, one of Europe’s largest medical universities, as well as at the Swiss Institute for Experimental Cancer Research. In 1989, he was recruited to UBC by the late Michael Smith, 1993 Nobel Laureate in Chemistry.

Jefferies’ work has explored the function of a brain protein called melanotransferrin that plays a key role in iron transport in central nervous system. He and colleagues discovered a link between the action of this molecule and Alzheimer’s disease. Another area of interest is looking at how the immune system detects aggressive cancer cells and how viruses become recognized by host lymphocytes. He has been involved in using TAP genes to resurrect the immune response in patients with metastatic tumours and the development of new tumour vaccines.

The author of numerous publications, Jefferies is funded by major agencies such as the Canadian Institutes of Health Research, the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council of Canada.

Hilary Thomson | EurekAlert!
Further information:
http://www.ubc.ca/

More articles from Life Sciences:

nachricht New way to look at cell membranes could change the way we study disease
19.11.2018 | University of Oxford

nachricht Controlling organ growth with light
19.11.2018 | European Molecular Biology Laboratory

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

New materials: Growing polymer pelts

19.11.2018 | Materials Sciences

Earthquake researchers finalists for supercomputing prize

19.11.2018 | Information Technology

Controlling organ growth with light

19.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>